Skip to main content
Company Info
News
Events & Presentations
Events Calendar
Presentations
Stock Information
Stock Info
Financial Information
Financial Results
SEC Filings
Governance
Governance Documents
Committee Composition
Management
Board of Directors
Resources
Investor Emails Alerts
Investor Contacts
RSS Feeds
Site Search
News
Company Info
News
Events & Presentations
Events Calendar
Presentations
Stock Information
Stock Info
Financial Information
Financial Results
SEC Filings
Governance
Governance Documents
Committee Composition
Management
Board of Directors
Resources
Investor Emails Alerts
Investor Contacts
RSS Feeds
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
12/26/2019
AgeX Therapeutics Announces Drawdown of Second Tranche of Loan Facility from Juvenescence Ltd.
12/10/2019
AgeX Therapeutics and Lineage Cell Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
12/09/2019
AgeX Therapeutics Issues Year-End Letter to Shareholders
11/14/2019
AgeX Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
11/08/2019
AgeX Therapeutics to Present at Investing in the Age of Longevity Conference
10/30/2019
AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform
10/11/2019
AgeX Therapeutics to Present at Metabesity 2019
09/09/2019
AgeX Therapeutics Presents at the Rodman & Renshaw Global Investment Conference
09/04/2019
AgeX Therapeutics Publishes Theoretical Basis Of Human Cell Age-Reversal In The Journal Regenerative Medicine
08/14/2019
AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
08/05/2019
Regenerative Medicine Leader Michael H. May Joins AgeX Board Of Directors
07/09/2019
AgeX Therapeutics’ CEO Dr. Michael D. West to Present at Ending Age-Related Diseases: Investment Prospects & Advances in Research
05/15/2019
AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
05/01/2019
AgeX Therapeutics to Participate at Biotech Investing in Longevity from Aikora Health and Foresight Institute
04/05/2019
AgeX Therapeutics to Present at Master Investor Show 2019
04/01/2019
AgeX Therapeutics Reports Fourth Quarter and Annual 2018 Financial Results and Provides Business Update
03/22/2019
AgeX Therapeutics Receives $4.5 Million From Exercise of Warrants
03/21/2019
AgeX Therapeutics to Present at Undoing Aging 2019, March 28-30 in Berlin, Germany
03/07/2019
LifeMap Sciences and iCarbonX Research Shenzhen Announce Strategic Collaboration
01/31/2019
AgeX Therapeutics to Present at Longevity Leaders Conference, February 4 in London
01/22/2019
AgeX Therapeutics’ CEO Dr. Michael D. West Presents at Precision Medicine World Conference 2019
01/10/2019
LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic Partnership to Offer Leading Clinical NGS Solution to the China Market
01/09/2019
AgeX Therapeutics Publishes Data in Peer-Reviewed Journal to Advance Potential Cell Therapy AgeX-BAT1 for Type II Diabetes and Obesity
01/02/2019
AgeX Therapeutics to Present at Biotech Showcase 2019